DLA Piper has advised H2APEX, a leading developer, operator and integrator of electrolysis plants for the production, storage and use of green hydrogen, on a capital increase on the Frankfurt Stock Exchange.
As part of the transaction, approximately 13.8 million new shares were issued from authorised capital, excluding shareholders’ subscription rights. The gross proceeds of around EUR 30 million will be used to finance the acquisition of HH2E Werk Lubmin GmbH and to further develop the existing hydrogen project in Lubmin. A portion of the new shares was subscribed through the conversion of a convertible loan.
DLA Piper had already advised the client in 2023 on the merger of exceet and APEX Group and the subsequent IPO.
H2APEX Group SCA, headquartered in Rostock-Laage (Germany) and Grevenmacher (Luxembourg), is listed in the Prime Standard segment of the Frankfurt Stock Exchange. Under the brand name H2APEX, the company develops, builds and operates green hydrogen plants to decarbonize industrial sectors such as steel, chemicals, cement and logistics, and is considered a pioneer in the field since shifting its focus entirely to hydrogen in 2012.
The DLA Piper team was co-led by partners Andreas Füchsel (Private Equity/M&A, Frankfurt) and Dr Roland Maaß a as well as counsel Juliane Poss (both Capital Markets, Frankfurt). The team included associates Alexander Hofsepjan and Benedikt Mail (both Capital Markets, Frankfurt).